View Author
cancer prostate prostate cancer expression androgen study tumor protein uptake xenograft model tissue receptor tumour imaging peptide patient growth level sample analysis analogue 346flu result control prostatic exosome prostate cancer cells gc 79 therapy differentiation pathway castration cell lines activity figure androgen withdrawal progression proteasome volume androgen-dependent factor effect androgen-independent disease marker injection serum binding carcinoma androgen receptor treatment c-met 0.000 choline antibody lncap 18 f-fch table response fusion biodistribution culture tumours point development etv 1 chromosome clone tumour uptake withdrawal radiolabelled system trial bombesin subunit -295 testosterone -310 sequence
10 Most Recent Publications
|
Activation of c-MET induces a Stem-Like phenotype in human prostate cancer
(Article)
Leenders, G.J. van Sookhlall, R. Teubel, W.J. Ridder, C.M.A. Reneman, S. Sacchetti, A. Vissers, K.J. Weerden, W.M. van Jenster, G.W. |
2011-11-14
|
|
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody
(Article)
Rij, C.M. van Sharkey, R.M. Goldenberg, D.M. Frielink, C. Molkenboer, J.D.M. Franssen, G.M. Weerden, W.M. van Oyen, W.J.G. Boerman, O.C. |
2011-10-01
|
|
Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines
(Article)
Marques, R.B. Dits, N.F. Erkens-Schulze, S. IJcken, W.F.J. van Weerden, W.M. van Jenster, G.W. |
2011-08-10
|
|
Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
(Article)
Emonds, K.M. Swinnen, J.V. Weerden, W.M. van Vanderhoydonc, F. Nuyts, J. Mortelmans, L. Mottaghy, F.M. |
2011-07-06
|
|
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
(Article)
Schroeder, R.P.J. Weerden, W.M. van Jong, M. de Krenning, E.P. Bangma, C.H. Berndsen, S.C. Grievink-De Ligt, C.H. Groen, H.C. Reneman, S. Blois, E. de Breeman, W.A.P. |
2011-07-01
|
|
Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation
(Article)
Gasi, D. Korput, H.A.G.M. van der Douben, H. Ridder, C.M.A. Weerden, W.M. van Trapman, J. Klein, J.E.M.M. de |
2011-02-07
|
|
Intraprostatic steroidogenic enzymes - Response
(Letter To Editor)
Hofland, J. Weerden, W.M. van Jenster, G.W. Schröder, F.H. Jong, F.H. de |
2010-10-15
|
|
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
(Article)
Schroeder, R.P.J. Müller, C. Reneman, S. Melis, M.L. Breeman, W.A.P. Blois, E. de Bangma, C.H. Krenning, E.P. Weerden, W.M. van Jong, M. de |
2010-07-01
|
|
Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts
(Article)
Schroeder, R.P.J. Visser, M. de Weerden, W.M. van Ridder, C.M.A. Reneman, S. Melis, M.L. Breeman, W.A.P. Krenning, E.P. Jong, M. de |
2010-06-15
|
|
Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer
(Article)
Hofland, J. Weerden, W.M. van Dits, N.F. Steenbergen, J. Leenders, G.J. van Jenster, G.W. Schröder, F.H. Jong, F.H. de |
2010-02-01
|
